Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sousuke Kubo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Clinical Respiratory Journal|July 30, 2024
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthmaKohei Somekawa, Keisuke Watanabe, Kenichi Seki, et al.
Open Forum Infectious Diseases|January 24, 2022
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After InfectionKei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, et al.
Frontiers in Microbiology|May 24, 2021
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 SurvivorsAtsushi Goto, Hirofumi Go, Kei Miyakawa, et al.
Translational Lung Cancer Research|April 11, 2024
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panelAmi Izawa, Yu Hara, Nobuyuki Horita, et al.
Translational Lung Cancer Research|March 21, 2025
Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter studyKohei Somekawa, Nobuaki Kobayashi, Satoshi Nagaoka, et al.
Thoracic Cancer|June 5, 2020
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trialNobuaki Kobayashi, Hisashi Hashimoto, Chisato Kamimaki, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 12, 2025
Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic reviewKohei Somekawa, Nobuyuki Horita, Satoshi Nagaoka, et al.
Scientific Reports|October 20, 2021
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approachYayoi Kimura, Yusuke Nakai, Jihye Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world settingRyosuke Tsugitomi, Kento Takagi, Go Saito, et al.
Targeted Oncology|April 13, 2024
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)Naoya Nishioka, Hisao Imai, Masahiro Endo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Clinical Respiratory Journal|July 30, 2024
Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthmaKohei Somekawa, Keisuke Watanabe, Kenichi Seki, et al.
Open Forum Infectious Diseases|January 24, 2022
Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After InfectionKei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, et al.
Frontiers in Microbiology|May 24, 2021
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 SurvivorsAtsushi Goto, Hirofumi Go, Kei Miyakawa, et al.
Translational Lung Cancer Research|April 11, 2024
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panelAmi Izawa, Yu Hara, Nobuyuki Horita, et al.
Translational Lung Cancer Research|March 21, 2025
Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter studyKohei Somekawa, Nobuaki Kobayashi, Satoshi Nagaoka, et al.
Thoracic Cancer|June 5, 2020
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trialNobuaki Kobayashi, Hisashi Hashimoto, Chisato Kamimaki, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 12, 2025
Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic reviewKohei Somekawa, Nobuyuki Horita, Satoshi Nagaoka, et al.
Scientific Reports|October 20, 2021
Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approachYayoi Kimura, Yusuke Nakai, Jihye Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world settingRyosuke Tsugitomi, Kento Takagi, Go Saito, et al.
Targeted Oncology|April 13, 2024
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)Naoya Nishioka, Hisao Imai, Masahiro Endo, et al.
Pageof 3